These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 838463)

  • 1. [A21-Asparaginimide] insulin. Saponification of insulin hexamethyl ester, I.
    Gattner HG; Schmitt EW
    Hoppe Seylers Z Physiol Chem; 1977 Jan; 358(1):105-13. PubMed ID: 838463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30.
    Markussen J; Diers I; Hougaard P; Langkjaer L; Norris K; Snel L; Sørensen AR; Sørensen E; Voigt HO
    Protein Eng; 1988 Jul; 2(2):157-66. PubMed ID: 3072564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystalline [A21-desamido]bovine insulin.
    Easter BR; Sutton DA; Drewes SE
    Hoppe Seylers Z Physiol Chem; 1978 Sep; 359(9):1229-36. PubMed ID: 711162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of two biologically active insulin analogues with modifications at the N-terminal and N- and C-terminal amino acid residues.
    Cosmatos A; Okada Y; Katsoyannis PG
    Biochemistry; 1976 Sep; 15(18):4076-82. PubMed ID: 963022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [21-arginine-A] insulin: a biologically active analog.
    Ferderigos N; Cosmatos A; Ferderigos A; Katsoyannis PG
    Int J Pept Protein Res; 1979 Jan; 13(1):43-53. PubMed ID: 422323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of a crystalline A1-(2-nitro-4-trimethylammoniophenyl) derivative of bovine insulin.
    Sutton DA; Easter BR; Drewes SE
    Hoppe Seylers Z Physiol Chem; 1976 Jul; 357(7):971-6. PubMed ID: 992573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational correlation and coupled motion between residue A21 and B25 side chain observed in crystal structures of insulin mutants at position A21.
    Zeng ZH; Liu YS; Jin L; Zhang Y; Havelund S; Markussen J; Wang DC
    Biochim Biophys Acta; 2000 Jun; 1479(1-2):225-36. PubMed ID: 11004541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large scale purification and characterization of A21 deamidated variant-most prominent post translational modification (PTM) for insulins which is also widely observed in insulins pharmaceutical manufacturing and storage.
    Shukla V; Srivatsa K; Madhu Kumar MS; Vajpai N; Agarwal N; Nethra S; Somesh BP; Kulshrestha A; Hazra P
    Protein Expr Purif; 2021 Sep; 185():105895. PubMed ID: 33957255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 2. [21-Asparagine diethylamide-A]insulin.
    Chu YC; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1987 Nov; 26(22):6972-5. PubMed ID: 3322394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and activity of insulin, XV[1-5]. Further evidence for the importance of arginine residue B22 in the activity of insulin. Semisyntheses of despentapeptide-(B23 - 30)-insulins varied in B22 using desnonapeptide-(B22 - 30)-insulin and tetrapeptides.
    Weitzel G; Bauer FU; Rehe Z
    Hoppe Seylers Z Physiol Chem; 1977 Dec; 358(12):1573-82. PubMed ID: 590940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 3. [21-Desasparagine,20-cysteine ethylamide-A]insulin and [21-desasparagine,20-cysteine 2,2,2-trifluoroethylamide-A]insulin.
    Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1987 Nov; 26(22):6975-9. PubMed ID: 3322395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (A14-phenylalanine)insulin: a new synthetic analogue.
    Danho W; Sasaki A; Büllesbach E; Gattner HG; Wollmer A
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):747-54. PubMed ID: 7000657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and activity of insulin, XVI. Semisyntheses of desheptapeptide-(B24--30)- up to destripeptide-(B28--30)-insulin with lysine or alanine in place of arginine in position B22: influence on the three-step-increase of activity in positions B24--26 (Phe-Phe-Tyr).
    Weitzel G; Bauer FU; Eisele K
    Hoppe Seylers Z Physiol Chem; 1978 Aug; 359(8):945-58. PubMed ID: 711155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 1. [21-Desasparagine,20-cysteinamide-A]insulin and [21-desasparagine,20-cysteine isopropylamide-A]insulin.
    Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1987 Nov; 26(22):6966-71. PubMed ID: 3322393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Displacement effect during HPLC preparative purification of human insulin.
    Gusarov D; Nekipelova V; Gusarova V; Lasman V; Bairamashvili D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1216-20. PubMed ID: 19286429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical synthesis of [des(tetrapeptide B27--30), Tyr(NH2)26-B] and [des(pentapeptide B26--30), Phe(NH2)25-B] bovine insulins.
    Cosmatos A; Ferderigos N; Katsoyannis PG
    Int J Pept Protein Res; 1979; 14(5):457-71. PubMed ID: 395118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous deamidation of a protein antibiotic, neocarzinostatin, at weakly acidic pH. Conversion to a homologous inactive preneocarzinostatin due to change of asparagine 83 to aspartic acid 83 accompanied by conformational and biological alterations.
    Maeda H; Kuromizu K
    J Biochem; 1977 Jan; 81(1):25-35. PubMed ID: 14934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of a crystalline tris-(N-methylpyridinium)-derivative of bovine insulin.
    Drewes SE; Sutton DA
    Hoppe Seylers Z Physiol Chem; 1976 Sep; 357(9):1261-6. PubMed ID: 992579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Partial synthesis and properties of des-A1-glycine-insulin (author's transl)].
    Brandenburg D; Biela M; Herbertz L; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):961-79. PubMed ID: 1237459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of partially protected des-alanineB30-insulin-B-chain-disulphide and its use in semisynthesis.
    Büllesbach EF; Schmitt EW; Gattner HG
    Int J Pept Protein Res; 1982 Sep; 20(3):207-17. PubMed ID: 6752063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.